http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004094396-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb1214e52bf0d7837fd1365200eacdc1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faa46d62e536f47e729f13c8dea49694 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4748ca2543283b53124f814111987ecc |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D279-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D279-12 |
filingDate | 2004-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd44aeef4d0f8978fe6547084bec870b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7798e4477419e9105da74d41f2df221e |
publicationDate | 2004-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2004094396-A2 |
titleOfInvention | Dihydrothiazine prodrugs of thiazolium agents |
abstract | Provided are compounds of the formula (and pharmaceutically acceptable salts thereof): (formula I) wherein: R is hydrogen, methyl, hydroxymethyl or α-hydroxyethyl; Rl and R2 are independently selected from hydrogen, C1-C6 alkyl, C1-C6 hydroxyalkyl, C3-C8 cycloalkyl, C1-C6 alkenyl, Cl-C6 alkynyl, amino, monoalkylamino, dialkylaminoalkyl, and pyrrolidin-1-ylalkyl; and Y is selected from the group consisting Of C1-C6 alkyl, substituted and unsubstituted aryl; with the provisos that: (a) if Y is aryl, then at least one of Rl and R2 is other than hydrogen, and (b) if R2 is hydrogen Rl is other than methyl. Also provided are pharmaceutical compositions containing the compounds, and methods for the preparation of the compounds. The compounds are useful, among other things, as prodrugs which can be converted under acidic conditions to thiazolium agents. The compounds can be administered to mammals, including humans, for treatment of various indications. |
priorityDate | 2003-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 621.